Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Next Science's share price for the quarter that ended in Jun. 2025 was $0.056. Next Science's Shares Outstanding (EOP) for the quarter that ended in Jun. 2025 was 292.16 Mil. Therefore, Next Science's market cap for the quarter that ended in Jun. 2025 was $16.36 Mil.
Next Science's quarterly market cap
declined
from Jun. 2024 ($49.27 Mil) to Dec. 2024 ($20.45 Mil) and
declined
from Dec. 2024 ($20.45 Mil) to Jun. 2025 ($16.36 Mil).
Next Science's annual market cap
declined
from Dec. 2022 ($90.73 Mil) to Dec. 2023 ($61.26 Mil) and
declined
from Dec. 2023 ($61.26 Mil) to Dec. 2024 ($20.45 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Next Science's Enterprise Value for Today is $4.62 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Next Science Market Cap Related Terms
Next Science Market Cap Historical Data
* Premium members only.
The historical data trend for Next Science's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Next Science's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Next Science Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Next Science's Market Cap distribution charts can be found below:
* The bar in red indicates where Next Science's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Next Science's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Next Science (NXSCF) has a Market Cap of $0.29 Mil as of Aug. 24, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Next Science and its competitors.
Is Next Science's Market Cap too high?
Next Science's current Market Cap is $0.29 Mil. The Drug Manufacturers industry median Market Cap is 231.41. Next Science's value of $0.29 Mil is 99.9% below this industry median.
How does Next Science's Market Cap compare to GCAN and PTPI?
Next Science's Market Cap of $0.29 Mil can be compared against companies in the Drug Manufacturers industry. The industry median Market Cap is 231.41. Next Science's value of $0.29 Mil is 99.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 231.41, based on 1,021 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Next Science's current Market Cap of $0.29 Mil is 99.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Next Science and its competitors. For the Drug Manufacturers industry, the median Market Cap is 231.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Next Science's current Market Cap is $0.29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Next Science stock overvalued right now?
Next Science (NXSCF) has a current Market Cap of $0.29 Mil. The stock's GF Value™ is $0.26, compared to a current price of $0.00 — trading 99.6% below its estimated fair value. The current Market Cap is $0.29 Mil and 99.9% below the Drug Manufacturers industry median of 231.41. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Next Science (NXSCF), the current Market Cap is $0.29 Mil as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Next Science Ltd is a medical technology company. It is engaged in the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections in human health. Xbio is a non-toxic technology with efficacy in eradicating both biofilm-based and free-floating bacteria. Its products include Bactisure, XEPERIENCE and BLASTX. The company derives revenue from North America, New Zealand, and Australia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NXSCF has been successfully added to your 
